Austin, TX, United States of America

Stas Emelianov

This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stas Emelianov. Retrieved from https://idiyas.com/inventor/stas-emelianov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 61(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Stas Emelianov: Innovator in Optical Coherence Tomography

Introduction

Stas Emelianov is a prominent inventor based in Austin, Texas. He has made significant contributions to the field of optical coherence tomography, particularly in the detection and treatment of cells. His innovative work has the potential to impact various medical applications.

Latest Patents

Stas Emelianov holds a patent titled "Optical coherence tomographic detection of cells and killing of the same." This patent outlines systems, methods, and compositions for utilizing optical coherence tomography to detect cells and subsequently kill those detected cells. The process involves applying energy to a particle comprised by the cell, which can lead to the injury or death of the cell.

Career Highlights

Emelianov is affiliated with the University of Texas System, where he continues to advance research in his field. His work is characterized by a commitment to innovation and the application of cutting-edge technology in medical diagnostics and treatment.

Collaborations

Stas Emelianov has collaborated with notable colleagues, including Marc D. Feldman and Thomas E. Milner. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation.

Conclusion

Stas Emelianov's contributions to optical coherence tomography exemplify the intersection of technology and medicine. His patent and ongoing research hold promise for future advancements in cell detection and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…